Sign up
Quantellect · Congress · Trade Detail
ITCIIntra-Cellular Therapies Inc. (ITCI) [ST]
DemocratHouse

Josh Gottheimer sold Intra-Cellular Therapies Inc. (ITCI) [ST] (ITCI)

Josh Gottheimer (D-NJ), a U.S. Representative, has disclosed 5 trades in Intra-Cellular Therapies Inc. (ITCI) [ST] (ITCI) since 2021, 1 purchase and 4 sales, worth an estimated $40K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a sale: Josh Gottheimer sold $1,001 - $15,000 of Intra-Cellular Therapies Inc. (ITCI) [ST] (ITCI) on January 24, 2025. Since that trade, ITCI is up +0.00% against the S&P 500 up +21.73%, an outperformance of -21.73%.

Across these filings, Josh Gottheimer has been a net seller of ITCI (a buy-to-sell ratio of 0.25). The most recent disclosed ITCI transaction shown was dated April 3, 2025. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

ITCI trades
5
Disclosed Vol
$40K
Buys
1
20%
Sells
4
80%
Buy / Sell
0.25
ratio
First → Last
2021–2025

Josh Gottheimer's ITCI trades vs the price

ITCI is up +0.00% since Josh Gottheimer sold on January 24, 2025, versus +21.73% for the S&P 500.

Performance since this trade

Price change since trade
+0.00%
S&P 500 change since trade
+21.73%
Outperformance vs S&P 500
-21.73%

All Josh Gottheimer ITCI trades

TradedTypeSizeReturnEst. profit
April 3, 2025SELL$1,001 - $15,000N/A
March 17, 2025SELL$1,001 - $15,000N/A
January 24, 2025SELL$1,001 - $15,000N/A
June 21, 2024SELL$1,001 - $15,000N/A
December 21, 2021BUY$1,001 - $15,000N/A

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Josh Gottheimer & ITCI trading FAQ

Is it legal for Josh Gottheimer to trade Intra-Cellular Therapies Inc. (ITCI) [ST] (ITCI) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Intra-Cellular Therapies Inc. (ITCI) [ST] (ITCI), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Josh Gottheimer sell ITCI?

Josh Gottheimer disclosed a sale of $1,001 - $15,000 of Intra-Cellular Therapies Inc. (ITCI) [ST] (ITCI) on January 24, 2025, according to public STOCK Act filings.

How has ITCI performed since Josh Gottheimer's trade?

Since Josh Gottheimer sold ITCI on January 24, 2025, the stock is up +0.00%, versus +21.73% for the S&P 500 over the same period, an outperformance of -21.73%.

How many times has Josh Gottheimer traded ITCI?

Josh Gottheimer has disclosed 5 ITCI trades since 2021 (1 purchase and 4 sales). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional ITCI trades?

Quantellect tracks every disclosed congressional trade in Intra-Cellular Therapies Inc. (ITCI) [ST] (ITCI) on the Intra-Cellular Therapies Inc. (ITCI) [ST] congressional trading page, which aggregates filings across all members of Congress.

Josh Gottheimer's ITCI tradesAll congressional filings for Intra-Cellular Therapies Inc. (ITCI) [ST]Josh Gottheimer's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.